CryptoNewsBreaks – Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) Subsidiary MindWave Innovations Announces $NILA Token Trading on PICOL in South Korea
Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS), through its wholly owned subsidiary MindWave Innovations Inc. USA, announced that $NILA, the native token of the MindChain network, began trading on PICOL, a cryptocurrency trading platform serving South Korean users, on Nov. 16, 2026, at 8:30 a.m. Eastern. Trading is available through the NILA/USDT pair, providing eligible users access to the token through manual trading and automated trading tools. The listing marks $NILA's first exchange listing focused on South Korea and expands its existing availability on Webot, LBank, Biconomy and Pionex. MindWave is developing MindChain, an Ethereum-based Layer 2 network designed to…





